Pamelor, Zoloft relieve postpartum depression

	Tweet

Two antidepressants—Pamelor (also called nortriptyline) and Zoloft (also called sertraline)—work equally well for women suffering postpartum major depression, according to results of a randomized comparative trial.

It has been assumed that antidepressants that are effective for major depression outside of childbearing are also efficacious for postpartum major depression, note investigators in the Journal of Clinical Psychopharmacology.

“Our results support this assumption,” write Dr. Katherine L. Wisner from the University of Pittsburgh Medical Center and colleagues. 

They treated 109 women with postpartum major depression with Pamelor or Zoloft for 8 weeks with a 16-week “continuation phase” to assess durability of response.

Of the 109 women treated, 95 provided response data at 4 weeks, 83 at 8 weeks, and 29 completed at least 20 weeks of the study.

The number of women who responded or remitted and the time to response did not differ markedly between the two drugs at any of the study’s time points, the investigators report.

At 4 weeks, 46 percent of Zoloft-treated women and 56 percent of Pamelor-treated women had responded and 27 percent and 30 percent, respectively, had remitted, “which is a reduction of symptoms consistent with full wellness,” Wisner told Reuters Health.

“Remission should be the goal of depression treatment in general, but is particularly important in these mothers of young children,” she added.

At 8 weeks, 56 percent of Zoloft-treated women and 69 percent of Pamelor-treated women had responded and 46 percent and 48 percent, respectively, had remitted.

Of those who remained on study until 20-24 weeks, 93 percent taking Zoloft and 100 percent taking Pamelor responded and 73 percent and 79 percent, respectively, remitted.

Psychological and social functioning improved similarly with both antidepressants and neither drug proved to be better than the other in treating aggressive obsessional thoughts.

“The total side effect burden of the two drugs was similar, although individual side effect profiles differed,” Wisner said.

“Breastfeeding mothers were included, and the infants had no observable adverse effects, similar to other reports and reviews in the literature,” she said.

SOURCE: Journal of Clinical Psychopharmacology August 2006.

RELATED STORIES:
Autism skews developing brain with synchronous motion and sound   Obesity in Teen Girls May Lead To Depressive Symptoms   Improving Communication with Families of Dying Patients Reduces Stress, Anxiety and Depression   Parkinson’s Patients More Likely to Stick With Certain ‘Add-On’ Drugs   Study Suggests Link Between Psychosis and Creativity   Smoking tied to risk of depression   Personality disorders linked to cardiovascular risk   Possible link between autism and airway abnormality   Study Suggests Salt Might be ‘Nature’s Antidepressant’   Adolescents with Autism Spend Free Time Using Solitary, Screen-Based Media   Genes may be responsible for obsessive-compulsive disorder   PTSD a risk factor for metabolic syndrome   Genetic link found between anxiety, depression and insomnia   New study in the journal SLEEP finds that chronic insomnia can lead to anxiety and depression   Watch for Preschool Depression

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]